arXiv · 2401.02149
AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptors
Abstract
Comparison of click chemistry and sortagging grafting strategies for functionalizing AGuIX nanoparticles with nanobodies to develop a tri-functional technology combining MRI imaging, radiotherapy, and immunotherapy by inhibiting immune checkpoints.
Explore related subjects
Keep this discovery
Léna Carmès, Guillaume Bort, François Lux, Léa Seban, Paul Rocchi, Zeinaf Muradova, Agnès Hagège, Laurence Heinrich-Balard, Frédéric Delolme, Virginie Gueguen-Chaignon, Charles Truillet, Stephanie Crowley, Elisa Bello, Tristan Doussineau, Michael Dougan, Olivier Tillement, Jonathan Schoenfeld, Needa Brown, Ross Berbeco. 2024-01-04. AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptors. https://doi.org/10.1039/d3nr04777f
Cite the original work for its findings. Save a collection to share your selection of sources.